Cargando…

6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level

The resistance of colorectal cancer (CRC) to chemotherapy, e.g., 5-fluorouracil (5-FU), is an impediment to successful cancer treatment. Although many mechanisms have been proposed to explain the occurrence of resistance, little is known concerning the role of the adipocyte-containing microenvironme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ko-Chao, Wu, Kuen-Lin, Yen, Chia-Kung, Chen, Cheng-Nan, Chang, Shun-Fu, Huang, Wen-Shih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537026/
https://www.ncbi.nlm.nih.gov/pubmed/34685438
http://dx.doi.org/10.3390/life11101067
_version_ 1784588149821800448
author Lee, Ko-Chao
Wu, Kuen-Lin
Yen, Chia-Kung
Chen, Cheng-Nan
Chang, Shun-Fu
Huang, Wen-Shih
author_facet Lee, Ko-Chao
Wu, Kuen-Lin
Yen, Chia-Kung
Chen, Cheng-Nan
Chang, Shun-Fu
Huang, Wen-Shih
author_sort Lee, Ko-Chao
collection PubMed
description The resistance of colorectal cancer (CRC) to chemotherapy, e.g., 5-fluorouracil (5-FU), is an impediment to successful cancer treatment. Although many mechanisms have been proposed to explain the occurrence of resistance, little is known concerning the role of the adipocyte-containing microenvironment of CRC. Accumulating data have proposed that the combined therapy of clinical drugs with ginger derivatives, e.g., 6-shogaol, might improve resistance development. In the present study, we examined the effect of adipocyte-conditioned medium (ACM) on 5-FU-treated CRC cells (human DLD-1 and SW480 cells) and further examined the possible antagonized role of 6-shogaol in this situation. It was shown that the level of sterol-regulatory element-binding protein-1 (SREBP-1), a critical transcription factor involved in lipid synthesis and metabolism, would be upregulated through Akt and p70S6K signaling pathways while CRC cells are cultured in ACM, which subsequently decreases the cell sensitivity to 5-FU cytotoxicity. Moreover, our results also demonstrated the antagonized role of 6-shogaol in attenuating the ACM effects on CRC cells through activating AMPK signaling. Overall, the present study elucidated the role of adipocyte-containing microenvironment in 5-FU resistance development of CRC through controlling the SREBP-1 level and further enhanced the concept of clinical application of 6-shogaol and AMPK signaling in CRC therapy.
format Online
Article
Text
id pubmed-8537026
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85370262021-10-24 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level Lee, Ko-Chao Wu, Kuen-Lin Yen, Chia-Kung Chen, Cheng-Nan Chang, Shun-Fu Huang, Wen-Shih Life (Basel) Article The resistance of colorectal cancer (CRC) to chemotherapy, e.g., 5-fluorouracil (5-FU), is an impediment to successful cancer treatment. Although many mechanisms have been proposed to explain the occurrence of resistance, little is known concerning the role of the adipocyte-containing microenvironment of CRC. Accumulating data have proposed that the combined therapy of clinical drugs with ginger derivatives, e.g., 6-shogaol, might improve resistance development. In the present study, we examined the effect of adipocyte-conditioned medium (ACM) on 5-FU-treated CRC cells (human DLD-1 and SW480 cells) and further examined the possible antagonized role of 6-shogaol in this situation. It was shown that the level of sterol-regulatory element-binding protein-1 (SREBP-1), a critical transcription factor involved in lipid synthesis and metabolism, would be upregulated through Akt and p70S6K signaling pathways while CRC cells are cultured in ACM, which subsequently decreases the cell sensitivity to 5-FU cytotoxicity. Moreover, our results also demonstrated the antagonized role of 6-shogaol in attenuating the ACM effects on CRC cells through activating AMPK signaling. Overall, the present study elucidated the role of adipocyte-containing microenvironment in 5-FU resistance development of CRC through controlling the SREBP-1 level and further enhanced the concept of clinical application of 6-shogaol and AMPK signaling in CRC therapy. MDPI 2021-10-10 /pmc/articles/PMC8537026/ /pubmed/34685438 http://dx.doi.org/10.3390/life11101067 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Ko-Chao
Wu, Kuen-Lin
Yen, Chia-Kung
Chen, Cheng-Nan
Chang, Shun-Fu
Huang, Wen-Shih
6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title_full 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title_fullStr 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title_full_unstemmed 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title_short 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
title_sort 6-shogaol antagonizes the adipocyte-conditioned medium-initiated 5-fluorouracil resistance in human colorectal cancer cells through controlling the srebp-1 level
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537026/
https://www.ncbi.nlm.nih.gov/pubmed/34685438
http://dx.doi.org/10.3390/life11101067
work_keys_str_mv AT leekochao 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level
AT wukuenlin 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level
AT yenchiakung 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level
AT chenchengnan 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level
AT changshunfu 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level
AT huangwenshih 6shogaolantagonizestheadipocyteconditionedmediuminitiated5fluorouracilresistanceinhumancolorectalcancercellsthroughcontrollingthesrebp1level